Profusa (PFSA) Cash from Operations (2022 - 2026)
Profusa (PFSA) reported Cash from Operations of 2600000.0 for Q1 2026, down 384.17% on a YoY basis from 914941.02 in Q1 2025, and up 49.31% quarter-over-quarter from 5129000.0 in Q4 2025.
Profusa (PFSA) Cash from Operations (2022 - 2026) Analysis & Trends
Profusa has reported Cash from Operations for 5 years, with the latest figure at 2600000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 384.17% year-over-year to 2600000.0; the trailing twelve-month figure through Mar 2026 stood at 18311000.0 (down 688.54% YoY), and the FY2025 full-year result was 16248000.0, down 686.45% from the prior year.
- Cash from Operations for Q1 2026 stood at 2600000.0, up from 5129000.0 in the prior quarter.
- The five-year high for Cash from Operations was 35386.0 in Q2 2025, with the low at 10617386.0 in Q3 2025.
- Historically, Cash from Operations has averaged 1385885.24 across 5 years, with a median of 345210.0 in 2023.
- The largest YoY upside for Cash from Operations was 108.96% in 2025 against a maximum downside of 2055.04% in 2025.
- Profusa's Cash from Operations stood at 179348.0 in 2022, then plunged by 92.48% to 345210.0 in 2023, then surged by 31.06% to 238000.0 in 2024, then tumbled by 2055.04% to 5129000.0 in 2025, then surged by 49.31% to 2600000.0 in 2026.
- The last three Cash from Operations figures came in at 2600000.0 (Q1 2026), 5129000.0 (Q4 2025), and 10617386.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Profusa | 1.37 Mn | 1.37 Mn | - | -2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.60 Mn |
| Mar 31, 2026 | -2.60 Mn |
| Dec 31, 2025 | -5.13 Mn |
| Dec 31, 2025 | -5.13 Mn |
| Sep 30, 2025 | -10.62 Mn |
| Sep 30, 2025 | -10.62 Mn |
| Jun 30, 2025 | 35,386.00 |
| Jun 30, 2025 | 35,386.00 |
| Mar 31, 2025 | -537,000.00 |
| Mar 31, 2025 | -537,000.00 |
| Dec 31, 2024 | -238,000.00 |
| Dec 31, 2024 | -238,000.00 |
| Sep 30, 2024 | -1.15 Mn |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -394,878.00 |
| Jun 30, 2024 | -394,878.00 |
| Mar 31, 2024 | -280,853.00 |
| Mar 31, 2024 | -280,853.00 |
| Dec 31, 2023 | -345,210.00 |
| Dec 31, 2023 | -345,210.00 |